Cases & Deals

Idenix challenges Gilead's patent rights to methods of treating HCV with Sovaldi® (sofosbuvir)

Clients Idenix Pharmaceuticals LLC

Jones Day represents Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co., Inc.) in a patent interference against Gilead. Subject matter is methods for treating a host infected with hepatitis C virus by administering a nucleoside analog or prodrug.

Storer v. Clark, Interference 105,981 (USPTO Patent Trial and Appeal Board)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.